. Purpose: Cigarette smoking is the main risk factor for chronic obstructive pulmonary disease and emphysema. However, evidence on the extrapulmonary effects of smoke exposure that precede lung impairments remains unclear at present, as are data on nonpharmacological treatments such as exercise training. Methods: Three groups of mice, including control (n = 10), smoking (n = 10), and smoking with 6 wk of high-intensity interval treadmill running (n = 11), were exposed to 20 wk of fresh air or whole-body cigarette smoke. Exercise capacity (peak oxygen uptake) and lung destruction (histology) were subsequently measured, whereas the heart, peripheral endothelium (aorta), and respiratory (diaphragm) and limb (extensor digitorum longus and soleus) skeletal muscles were assessed for in vivo and in vitro function, in situ mitochondrial respiration, and molecular alterations. Results: Smoking reduced body weight by 26% (P G 0.05) without overt airway destruction (P 9 0.05). Smoking impaired exercise capacity by 15% while inducing right ventricular dysfunction by~20%, endothelial dysfunction by~20%, and diaphragm muscle weakness by~15% (all P G 0.05), but these were either attenuated or reversed by exercise training (P G 0.05). Compared with controls, smoking mice had normal limb muscle and mitochondrial function (cardiac and skeletal muscle fibers); however, diaphragm measures of oxidative stress and protein degradation were increased by 111% and 65%, respectively (P G 0.05), but these were attenuated by exercise training (P G 0.05). Conclusions: Prolonged cigarette smoking reduced exercise capacity concomitant with functional impairments to the heart, peripheral endothelium, and respiratory muscle that preceded the development of overt emphysema. However, highintensity exercise training was able to reverse these smoke-induced extrapulmonary impairments.
C igarette smoking is the main risk factor for chronic obstructive pulmonary disease (COPD). This is characterized not only by airway destruction and airflow limitation but also by extrapulmonary impairments to the heart (12, 25) , peripheral vasculature (6, 27) , and skeletal muscles (2, 3, 18, 24) , which collectively exacerbate the key symptom of exercise intolerance. Interestingly, initial evidence suggests that smokers at risk of COPD may also suffer extrapulmonary impairments similar to those demonstrated in smokers with COPD (11, 31) . However, data detailing the extrapulmonary effects of prolonged smoke exposure in the period preceding COPD remain unclear at present, as are data on potential favorable therapeutic interventions. For example, it remains unknown whether smoke-induced extrapulmonary impairments in the heart, endothelium, and respiratory and limb skeletal muscle occur in parallel as a direct consequence to cigarette smoke (i.e., primary effect) or as an indirect consequence after the subsequent development of emphysema (i.e., secondary effect) (2, 3, 7, 13) . In addition, data on whether prolonged smoke exposure induces skeletal muscle dysfunction in the lower limbs remain controversial, with some (24, 28) but not all (7, 34 ) studies reporting impairments. Further, whether smoking directly induces respiratory (i.e., diaphragm) fiber contractile dysfunction remains unknown, despite the diaphragm playing a direct role in the pathogenesis of dyspnea in smokers (11) and also not being affected by disuse (as is common for the lower limb muscles (7)). As such, more evidence is needed to clarify the role of cigarette smoke on respiratory and limb skeletal muscle contractile function.
Interestingly, physical inactivity has recently been demonstrated to exacerbate the extrapulmonary impairments associated with prolonged cigarette smoking (7), whereas exercise training has been shown to reverse smoke-induced cardiac dysfunction in mice (15) . Yet whether exercise training can also reverse numerous smoke-induced systemic impairments related not only to cardiac function but also to the peripheral endothelium as well as respiratory and locomotor skeletal muscles remains unknown. In this study, therefore, we exposed mice to cigarette smoke followed by the intervention of high-intensity exercise training and used an integrative approach by combining measures of the lung and exercise capacity in parallel with multiple-extrapulmonary organs. We hypothesized that cigarette exposure would impair cardiac, endothelial, respiratory, and limb muscle function before the development of overt emphysema and that exercise training would be able to attenuate such impairments.
MATERIALS AND METHODS
Animals and smoke exposure. Ten-week-old A/ JOlaHsd female mice (Harlan Laboratories, UK) were used in this study, as approved by the Norwegian Animal Research Authority and in accordance with ACSM"s animal care standards. This study lasted a total of 26 wk: 0 to 20 wk, the mice were exposed to either fresh air or cigarette smoke, 20 to 26 wk, the mice performed exercise training or remained sedentary, and at week 26 mice were killed. Briefly, mice were randomly separated into three groups to receive 1) fresh air (control mice; n = 10), 2) cigarette smoke (smoking mice; n = 10), or 3) cigarette smoke and high-intensity interval exercise training (smoking + high-intensity interval training [HIIT] mice; n = 11). The exposure period consisted of 6 hId j1 for 5 dIwk j1 , and this was achieved by placing mice in a chamber connected to a smoking device (TE-10; Teague Enterprises, Woodland, CA), which provided fresh air or cigarette smoke (Research Cigarettes 3R4F; University of Kentucky, Lexington, KY). The total particulate matter was 100 mgIm j3 for the first 2 wk and 200 mgIm j3 for the remaining exposure time (a level of 250 total particulate matter has been suggested to be equivalent to humans smoking around 15 packs per day (21)), which was monitored weekly and measured with gravimetric method as previously described (20) . The exposure period was terminated after 20 wk, and the exercise training intervention was then performed.
Exercise training and exercise capacity. HIIT was performed on a treadmill (25-incline) five times per week for 6 wk. Each session consisted of 10 intervals (4 min at~9 0% peak work rate) separated by a 2-min recovery (~60% peak work rate). Exercise capacity was assessed in all mice by measuring peak oxygen uptake (V O 2peak ) in milliliters per minute via a closed metabolic chamber, as previously described (17) .
In vivo cardiac function and hemodynamics. Echocardiography was performed as previously described (15) . Briefly, in the week before sacrifice, mice were anesthetized with 2% isoflurane adjusted to maintain similar heart and respiration rates between animals. The echocardiography system with a 24-MHz probe was used to determine both right and left ventricular function (Vevo 2100; Visual Sonics, Toronto, Canada). Right ventricular systolic function was assessed by measuring the tricuspid annular plane systolic excursion (TAPSE), which was defined as the differences in systolic and diastolic displacement of the right ventricular base, as obtained from the apical four chamber view in B-mode. This included the M-mode cursor being oriented to the junction of the tricuspid valve plane in the right ventricular free wall and through the apex. Right ventricular systolic velocity was obtained from the apical four chamber view using tissue Doppler from the lateral wall close to the tricuspid inflow. Pulmonary acceleration pressure, defined as the onset of pulmonary flow to the peak flow, was measured using pulsedwave Doppler in the short-axis view at the level of the aortic valve. In addition, left ventricular function was assessed using B-mode images in the parasternal short-axis view to calculate left ventricular ejection fraction, whereas left ventricular fractional shortening was calculated in M-mode. In vivo hemodynamics of the right ventricular systolic pressure was also determined as previously described (33) . Briefly, immediately before sacrifice, mice were anesthetized with 2% isoflurane under spontaneous breathing, and the external jugular vein was dissected free and a 1.2-F pressure catheter inserted to determine right ventricular systolic pressure (Scisense pressure catheter FTH-1211B-0018; Scisense Inc., London, Canada). Data were acquired with Advantage PV System ADV500 (Transonic Inc., London, Canada). Body temperature was measured with a rectal probe, which was kept constant at 37.5-C during the experiment. The animal was observed until stable readings before recording. The animals were killed immediately after the recordings by removal of the heart. Data were analyzed with LabChart version 7 (ADInstruments, Oxford, UK). Right ventricular systolic pressure was used as an index of pulmonary hypertension, which is usually developed during emphysema.
Lung emphysema. The right lung was inflated by instilling a 4% formaldehyde phosphate-buffered solution via the trachea at a pressure of 25 cm H 2 O. It was maintained to fixate like this for a minimum of 15 min before ligating the right main bronchus and putting the whole specimen in formaldehyde solution. Later, it was paraffin embedded, sectioned, and stained with hematoxylin, eosin, and saffron. Light microscopy was then used to identify suitable areas free from artifacts, and four to eight images per animal were selected on a random basis. A reference grid was placed on images to count the points of intercepts between the grid lines and the alveolar walls, followed by dividing this number by the total length of all grid lines, to determine the mean linear intercept length, as previously detailed (10) .
In vitro skeletal muscle function. A diaphragm strip, the soleus, and the extensor digitorum longus (EDL) were isolated and stimulated across a range of frequencies for measurement of in vitro isometric contractile function, as previously described (5). Muscle force (N) was normalized to muscle cross-sectional area (cm 2 ) by dividing muscle mass (g) by the product of optimal muscle length (cm) and estimated muscle density (1.06) (8) , which allowed specific force in newton per square centimeter to be calculated.
In vitro peripheral vascular endothelial function. To provide an index of vascular function, aortic rings (n = 4 per mouse) were dissected from mice and mounted in a bufferfilled (in mmolIL j1 : 118 NaCl, 25 NaHCO 3 , 4. , Sigma) were recorded until no further changes were observed to determine endothelial-dependent and endothelial-independent vasodilation, respectively.
In situ mitochondrial respiration. Mitochondrial respiration was measured in situ from permeabilized cardiac and diaphragm fibers using high-resolution respirometry (Oxygraph2k; Oroboros Instruments, Innsbruck, Austria), as previously described (5) . Dissected fibers were immediately placed in ice-cold BIOPS (2.77 mM CaK 2 EGTA buffer, 7.23 mM K 2 EGTA buffer, 20 mM imidazole, 20 mM taurine, 50 mM 2-(N-morpholino)ethanesulfonic acid hydrate, 0.5 mM dithiothreitol, 6.56 mM MgCl 2 I6H 2 O, 5.77 mM Na 2 ATP, and 15 mM Na 2 PCr [pH 7.1]) and under a microscope carefully dissected in 2 mL BIOPS at 4-C and permeabilized in saponin (50 KgImL j1 ) for 30 min. Fiber bundles were then transferred to 2-mL ice-cold mitochondrial respiration medium (MiR05; 0.5 mM EGTA, 3 mM MgCl 2 I6H 2 O, 60 mM lactobionic acid, 20 mM taurine, 10 mM KH 2 PO 4 , 20 mM HEPES, 110 mM d-sucrose, and 1 gIL j1 bovine serum albumin essentially fatty acid free, pH 7.1) and gently agitated for 10 min at 4-C before placed in a 2-mL oxygraph chamber incubated in MIR05 at 37-C oxygenated at~300-400 KM (Oxygraph-2k, Oroboros, Innsbruck, Austria). All experiments were performed in duplicates. A protocol evaluating both leak (L) and oxidative phosphorylation (P) respiration states in complex I (C I ) and complex I + II (C I + II ) was assessed by addition of malate (2 mM) and glutamate (10 mM), followed by saturating adenosine diphosphate (5 mM) and then succinate (10 mM), respectively. All measurements (pmol O 2 Is j1 Img j1 ) were normalized to muscle wet weight. In addition, the respiratory control ratio was calculated as the ratio of maximal C I (P C I ) to leak state (L C I ) respiration, and also a substrate control ratio was calculated as P C I to P C I + II .
Tissue analyses. Fiber typing and cross-sectional area analyses were performed on diaphragm sections, as previously described (5) . Protein expression of MuRF1, MAFbx, NADPH oxidase (subunit gp91 phox ), myosin heavy chain, and eNOS (phosphorylated and acetylated) was assessed by western blot, whereas enzyme activity of NADPH oxidase, catalase, and superoxide dismutase was quantified in a photometric manner, as previously described (5) . All data are presented as fold change relative to sham.
Statistical analyses. Data are presented as mean T SEM. Between-group differences in terms of physical characteristics, cardiac function, V I O 2peak , mitochondrial function, protein expression, and enzyme activity were assessed by one-way ANOVA (Bonferroni"s post hoc test) or nonparametric Kruskal-Wallis (Dunn"s post hoc test). Endothelial function (group-concentration) as well as force frequency (group-frequency) and fatigue protocols (group-time) from each skeletal muscle were assessed by two-way repeatedmeasures ANOVA with Bonferroni post hoc analysis. Statistical significance was accepted as P G 0.05.
RESULTS
Smoke exposure in mice reduced body weight by 26% (P G 0.05; Fig. 1A ) and impaired exercise capacity by 15% (P G 0.05 ; Fig. 1B) ; however, the latter was normalized after exercise training (P 9 0.05; Fig. 1B ). In addition, in line with our hypothesis, cigarette smoke exposure did not cause the development of overt emphysema, as demonstrated by no discernable alveolar destruction (i.e., mean linear intercept remained unchanged; P 9 0.05; Fig. 1C ) and by the absence of pulmonary hypertension (i.e., right-ventricular systolic pressures were unchanged; P 9 0.05; Fig. 1D ). Similarly, no differences were found between groups in terms of tibia length or skeletal muscle wet weights (P 9 0.05).
Smoke-induced Extrapulmonary Impairments
Heart. Heart weight remained unaltered after cigarette smoking (P 9 0.05). In addition, although echocardiography revealed that left ventricular function was not impaired by smoking (P 9 0.05; Table 1 ), right ventricular systolic function was reduced compared with controls by~20% as assessed by TAPSE (P G 0.05; Table 1 ). To determine whether mitochondrial dysfunction may underlie this impairment, we further assessed mitochondrial respiration in fibers from the right and left ventricle, but found no differences (P 9 0.05; Fig. 2A and B) .
Peripheral endothelium. The effect of smoking on peripheral endothelial function was assessed from isolated aortic rings for both endothelial-dependent and endothelialindependent vasodilation (i.e., relaxation). The stimulation of aortic rings with increasing concentrations of acetylcholine revealed that smoking was associated with impaired endothelial-dependent vasodilation (P G 0.05; Fig. 3A) , with smoke-exposed mice achieving only 70% T 7% of their maximal dilation compared with control mice values of 91% T 3% (P G 0.01). By contrast, smoke exposure did not impair endothelium-independent vasodilation (P 9 0.05; Fig. 3B) , with maximal vasodilation values of 100% achieved in both groups (P 9 0.05). To determine potential mechanisms underlying these functional impairments, we further assessed protein expression of phosphorylated eNOS and acetylated eNOS in the aorta but found no differences between control and smoke-exposed mice (P 9 0.05).
Respiratory and limb skeletal muscles. Compared with controls, diaphragm fiber bundles from smoking mice were weaker by an average of 15% T 2% (range: 11%-19%; P G 0.05; Fig. 4A ), which occurred at the lower and more clinically relevant frequencies of 1, 15, 30, and 50 Hz. However, no differences were discerned during the fatigue protocol between groups. In contrast to the diaphragm, smoking had no adverse effect on limb muscle contractile function for either the glycolytic EDL muscle (Fig. 4B) or the oxidative soleus muscle (Fig. 4C) , or on relative force during the fatigue protocol (P 9 0.05; data not shown). As these data suggested the diaphragm was more susceptible to cigarette smoke-induced impairments; we focused thereafter on this specific skeletal muscle. Histological analyses of the diaphragm between control and smoke-exposed mice revealed no structural changes in terms of fiber cross-sectional area (fast and slow twitch: 1077 T 102 vs 1222 T 82 Km 2 and 895 T 123 vs 877 T 76 Km 2 , respectively; P 9 0.05) or fiber proportions (fast and slow twitch: 92% T 1% vs 92% T 1% and 8% T 1% vs 8% T 1%, respectively; P 9 0.05). By contrast, although the protein expression of NADPH oxidase, a marker of oxidative stress, was unaltered between groups (P 9 0.05; Fig. 5A ), the more functional measure of enzyme activity was increased by 111% (P G 0.05; Fig. 5B) . Similarly, the protein expression of MAFbx (a key marker of protein degradation) was also increased by 65% in smokers compared with controls (P G 0.05; Fig. 5C ). By contrast, however, the protein expression of MuRF1 (another marker of protein degradation) was not different between groups (P 9 0.05; 5D), as was the case for the contractile protein myosin heavy chain (1.00 T 0.17 vs 0.90 T 0.15; P 9 0.05). We further assessed whether mitochondrial dysfunction could be contributing to the diaphragm muscle weakness after smoke exposure; however, in situ mitochondrial respiration of permeabilized fibers was not different between groups (P 9 0.05; Fig. 2C ).
Effects of High-Intensity Exercise Training in Smoke-exposed Mice
Six weeks of exercise training normalized the smokeinduced reduction in exercise capacity (Fig. 1B) , while also improving left ventricular systolic function (i.e., ejection fraction and fractional shortening) when compared with sedentary smoke-exposed mice (P G 0.05; Table 1 ). In addition, exercise essentially reversed the smoke-induced impairment of TAPSE, suggesting right ventricular function was normalized (P G 0.05; Table 1 ), while also reversing peripheral endothelial dysfunction such that maximal endotheliumdependent dilation was normalized to control values (P 9 0.05; Fig. 3A ). In line with this, we found the protein expression of phosphorylated eNOS to be increased in the aorta of smoke-trained mice compared with both control and smoke-exposed sedentary mice (P G 0.05). Importantly, smoke-induced diaphragm contractile dysfunction was also reversed by exercise training to similar values of that observed in control mice (P 9 0.05; Fig. 4A ), which was also the case for both the enzyme activity of NADPH oxidase (P 9 0.05; Fig. 5B ) and the protein expression of MAFbx (P 9 0.05; Fig. 5C ). Nevertheless, no differences were subsequently found between control, smoking, and smoke-trained mice in terms of the antioxidative enzyme activity of superoxide dismutase (1.00 T 0.09 vs 1.22 T 0.22 vs 1.30 T 0.23, respectively; P 9 0.05) or catalase (1.00 T 0.13 vs 1.01 T 0.13 vs 0.83 T 0.12, respectively; P 9 0.05). Furthermore, exercise training had no influence on the expression of other proteins (e.g., myosin heavy chain, MuRF1, and NADPH oxidase) on fiber properties (i.e., cross-sectional area and type) or on mitochondrial function ( Fig. 2C ; all P 9 0.05).
DISCUSSION
The main findings of this study are as follows: 1) cigarette smoking induced functional impairments to the heart, FIGURE 2-In situ mitochondrial respiration states and the respective control ratios in permeabilized fibers of the left ventricle (A), right ventricle (B), and diaphragm (C), as assessed from control, smoking, and smoking mice that performed HIIT. Respiration states were assessed, in turn, including the following: C I leak, complex I leak respiration after the addition of malate and glutamate; C I , complex I phosphorylated state after the addition of ADP; C II , complex II phosphorylated state after the addition of succinate. No significant differences were found between groups for all measures.
peripheral endothelium, and respiratory muscle, which occurred in the absence of overt emphysema and these likely converged to reduce exercise capacity, and 2) highintensity exercise training reversed these smoke-induced extrapulmonary impairments in line with normalizing exercise capacity. Collectively, therefore, our findings may have important clinical implications as they suggest that cigarette smokers in the absence of emphysema likely develop simultaneous extrapulmonary impairments to the heart, peripheral endothelium, and diaphragm that exacerbate exercise intolerance (11, 31) , but such maladaptations could be reversed by the nonpharmacological intervention of exercise training.
Smoke exposure and skeletal muscle function. Skeletal muscle dysfunction is a key component of COPD (19) and is associated with numerous adaptations (e.g., fiber atrophy, mitochondrial dysfunction, and increased reactive oxygen species) (2, 3, 18, 24) , yet numerous studies have yielded contradictory results with some (24,28), but not all (7, 34) , showing contractile impediments in the lower limbs. In these previous studies, however, overt emphysema had either developed (7, 24) or was not reported (18, 28) , leaving it difficult to discriminate whether the cigarette smoke or emphysema was the causal factor underlying skeletal muscle dysfunction. Our study indicates that cigarette exposure in the absence of emphysema does not induce limb muscle contractile dysfunction, as supported by findings in both highly oxidative (i.e., soleus) and glycolytic (i.e., EDL) muscles. In addition, muscle disuse may have also confounded previous studies where limb muscle dysfunction was reported, as recent data demonstrated physical inactivity combined with smokeinduced emphysema significantly exacerbates limb muscle impairments (7). In the current experiments, therefore, we also assessed the main muscle of respiration, the diaphragm, which is not only constantly active (i.e., thus attenuating any potential confounding factors associated with disuse) but also FIGURE 4-In vitro respiratory and lower limb skeletal muscle contractile function assessed across a range of stimulation frequencies in the diaphragm (A), EDL (B), and soleus (C) for control, smoking, and smoking mice that performed HIIT. *P G 0.05 vs smoking. is thought to play a direct role in the pathogenesis of dyspnea (a key symptom in smokers even without overt COPD (11)). In the present study, we provide novel evidence that prolonged smoking induces diaphragm contractile dysfunction that is independent of lung structural damage, with fiber bundles~15% weaker compared with control mice. These data suggest, therefore, a greater sensitivity of respiratory rather than locomotor striated muscle to cigarette smokeinduced dysfunction. Furthermore, this loss of function was not due to muscle atrophy as force was normalized to muscle density, which suggests fiber weakness induced by smoking was the result of intracellular impairments (i.e., contractile dysfunction).
Although diaphragm muscle weakness in emphysema has previously been observed in diaphragm fibers from humans (23) and animals (32), we are the first to provide direct evidence that cigarette smoke exposure can lead to diaphragm fiber weakness in the period preceding lung structural damage. The mechanisms underlying the smoke-induced diaphragm muscle weakness may be related to an increase in oxidative stress and protein degradation, as NADPH oxidase activity (but not protein content) and MAFbx protein expression were increased in the diaphragm of smoking mice, but these were attenuated in the smoke-exercise-trained mice in parallel with normalized contractile function. These findings compliment previous studies, which also reported increased levels of oxidative stress and oxidative protein modifications in the diaphragm after prolonged cigarette smoking in mice (2, 3) . However, contrary to data from the soleus muscle (29) , mitochondrial dysfunction was not present in diaphragm fibers after prolonged smoke exposure, which suggests a low oxidative phosphorylation capacity was unlikely mediating the smoke-induced respiratory muscle weakness. Taken together, therefore, our data support a role for cigarette smoking as a causal mechanism in diaphragm muscle weakness, potentially mediated by elevated oxidative stress levels and activation of proteolytic pathways, which likely predisposes many smokers to respiratory dysfunction in the period preceding emphysema (11) .
Smoke exposure and cardiovascular function. After prolonged smoke exposure, cardiac dysfunction is known to develop, with right ventricular function particularly compromised (25) , whereas peripheral vascular endothelial dysfunction is also manifest (27) . Our study confirmed that right ventricular function is reduced and peripheral endothelial function is impaired after cigarette exposure, which occurred in the absence of overt emphysema. In addition, we also confirmed previous findings that right ventricular dysfunction can be reversed by exercise training (15) . To better understand the mechanisms of these smoke-induced cardiac impairments, we assessed mitochondrial function in cardiac fibers. However, and in contrast to a previous study reporting impaired respiration in fibers from the left ventricle (30), we found no differences between groups in either the left or right ventricle, which suggests mitochondrial dysfunction is unlikely a key mechanism of smoke-induced right ventricular dysfunction, at least in relation to the present animal model. In terms of the peripheral endothelium, we provide novel data that high-intensity exercise training can reverse smoke-induced peripheral vascular impairments, as endothelium-dependent vasodilation in aortic rings was normalized to control values after exercise training. We also found a significant increase in the protein expression of phosphorylated eNOS in smoketrained mice, which may help explain how exercise mediated its benefits, as smoking is well known to reduce NO bioavailability and eNOS activity (4). However, why endothelial dysfunction was only observed at the higher rather than the lower acetylcholine concentrations in smoke-exposed mice is unclear, but it may be related to differences in membrane receptor sensitivity or density. Nevertheless, that data collected from both animals (27) and humans (16, 26) show a similar trend after smoke exposure supports the physiological relevance of the present findings.
If we take an integrative approach, it could be speculated that diaphragm muscle weakness induced by smokeexposure is mediated, in part, by upstream impairments related to cardiac and peripheral endothelial dysfunction that limit blood flow to induce local hypoxia, with the latter suggested as a key mechanism underpinning skeletal muscle dysfunction in COPD (19) . Hypoxia has been shown in diaphragm fiber bundles to potentiate ROS production, which, in turn, directly impair subsequent force generation (22) . As such, our overall findings of impaired central and peripheral vascular function coupled with diaphragm muscle weakness in concert with elevated markers of ROS suggest hypoxia could be a putative mechanism for the smoke-induced respiratory muscle weakness.
Animal model of cigarette smoke exposure. The uncertainty related to the role of cigarette smoke exposure on extrapulmonary impairments had previously been clouded by the fact that emphysema was usually developed secondary to cigarette exposure (2, 3, 7, 13) or that lung indices of emphysema were not measured (18, 28) . In the current study, we selected a period of 20 wk for smoke exposure so animals would not develop overt emphysema, which is generally documented after 24 wk in mice (9, 13) . Furthermore, the A/J mouse strain we studied is moderately susceptible to lung destruction after smoke exposure (21), but not as sensitive (e.g., C57BL/6J) or resistant as other strains (e.g., NZWLac/J) (14, 35) . Collectively, therefore, the present data support our objective and reinforce the clinical translation of our data, as prolonged smoke exposure resulted in no signs of emphysema, whereas numerous multiorgan impairments converged concomitant with an impaired exercise capacity of 20%, with the latter value similar to that reported in patients at high risk of developing emphysema (11) . Nevertheless, we acknowledge the possibility that our mouse model may have still induced lung injury and airflow limitation despite the absence of emphysema histologically. As such, the addition of lung functional measurements, including measuring airway resistance, would have provided further clarity on this issue. Furthermore, as the present study assessed female mice only, it also remains unclear whether the observed multiorgan impairments would have been reduced or exacerbated in males exposed to the same amount of cigarette smoke.
CONCLUSION
High-intensity exercise training reversed cigarette smokeinduced extrapulmonary impairments to the heart, the peripheral vascular endothelium, and the diaphragm and normalized exercise capacity, which occurred before the onset of overt emphysema. These findings suggest, therefore, that cigarette smokers in the absence of emphysema likely develop extrapulmonary impairments that exacerbate exercise intolerance, but exercise training can reverse these detrimental consequences.
